It has also recently been shown that ENAM can suppress cell proliferation in ccRCC and significantly increase cytotoxic cells, CD56 NK cells, NK cells, and CD8 + T cells in the immune TME14. This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.